Study of COVID-19 Effects and Long-Term Impact on Children in Taiwan Including Multisystem Inflammatory Syndrome and Long COVID
Led by National Taiwan University Hospital · Updated on 2023-11-18
3000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research investigates severe COVID-19 factors in children, including host genes, biomarkers, and the prognosis of severe encephalitis. The study includes retrospective analysis of pediatric COVID-19 cases to identify severe disease factors, prospective assessment of host-virus interactions and severity, and long-term tracking of children with Long COVID-19 Syndrome. It also explores seroepidemiology among healthcare workers and the community to better understand infection profiles and immune responses in children.
The study consists of multiple groups a retrospective group analyzing clinical data from hospitalized children under 18 an acute case group including children with multisystem inflammatory syndrome a long COVID-19 tracking group conducting systematic outpatient assessments of body, lung, neurological, and psychological function a seroepidemiological group studying antibody prevalence among healthcare workers and the public and a healthy control group. Various tests include whole exome sequencing, microbiota analysis, biomarker measurement, brain MRI, neurophysiological exams, and immune function tests.
Participants undergo evaluations including physical exams, neurological and pulmonary function tests, brain imaging, neuropsychological assessments, psychiatric interviews, and laboratory tests for immune and inflammatory markers. Monitoring includes heart rate variability, sleep studies, and antibody testing. The main outcomes measured are risk factors and complications over 3 months, fatigue levels at one month, and COVID-19 seropositivity on a single day. The study aims to clarify the long-term effects of COVID-19 on childrens health and immunity, with expected participation of several thousand children and adults.
CONDITIONS
Brief Title
Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan
Research Team
T
Tsui-Yien Fan, RA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Presence of metal implants or devices that cannot be removed, such as braces, metal nails, artificial electronic ears, or pacemakers
Major physical diseases
Sensory impairments such as deafness
Movement disorders such as cerebral palsy
Uncontrolled and stable epilepsy
Pregnancy or uncertainty about pregnancy status
History of hypoxia due to encephalitis or other causes not related to enterovirus infection
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Clinical Characteristics Data Collection
Duration - Retrospective data collection covering January 1, 2020 to June 13, 2022
Participants who were COVID-19 positive and younger than 18 years old have their clinical data retrospectively collected and analyzed to identify risk factors and complications.
No visits required (retrospective study)
Acute Case Receiving Group Assessments
Duration - 7 to 14 days for physiological monitoring; other assessments as scheduled
Participants with acute COVID-19 or multisystem inflammatory syndrome undergo tests including host gene studies, microbiota, immune biomarkers, neurological, pulmonary, brain imaging, physiological monitoring, and other clinical examinations based on symptoms.
Multiple visits depending on tests needed
Children's Long COVID-19 Tracking
Duration - Long-term tracking over several months to years
Participants with long COVID-19 are systematically tracked through outpatient visits assessing body, lung function, neurological and psychological status, including brain MRI, neurophysiological exams, psychiatric interviews, cognitive testing, and immune function analysis.
Multiple outpatient visits scheduled over time
Seroepidemiological Research
Duration - 6 months
Participants including medical staff and general public undergo blood draws for COVID-19 antibody testing at baseline, 3 months, and 6 months to understand antibody prevalence and decline.
3 visits for blood draws (baseline, 3 months, 6 months)
Healthy Control Group Assessments
Duration - Assessment scheduled to match acute case group timing
Healthy participants undergo assessments including respiratory and intestinal microbiota analysis, immune biomarkers, brain MRI, neurophysiological exams, brain injury biomarkers, and host transcriptome research to serve as controls.
Multiple visits depending on assessments
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Similar Trials
Randomized Clinical Trial of Acupuncture for Treating Neuropsychiatric Symptoms of Long COVID in Adults
Using Cardiac MRI and Echocardiogram to Study Heart and Lung Effects and Predict Health Outcomes in Adults After COVID-19
Study of Cardiovascular Disease Progression After Severe Pneumonia and COVID-19 Lung Infection in Adults
Study of COVID-19 Effects and Long-Term Impact on Children in Taiwan Including Multisystem Inflammatory Syndrome and Long COVID
Observational Study on the Effects of COVID-19 on Pregnancy Outcomes and Child Development
Study of 2-HOBA Treatment to Reduce Immune Activation and Improve Symptoms in Long COVID Patients with Postural Tachycardia Syndrome POTS
Evaluating Transcranial Direct Current Stimulation for Persistent COVID-19 Symptoms
Including Headaches and Chronic Pain
Mindfulness Intervention for Long COVID Symptoms to Reduce Stress and Improve Quality of Life
Validation Study of the A&M Breathalyzer PROTECT Kiosk for Detecting COVID-19 and Other Respiratory Infections
Non-interventional Observational Study at Brooke Army Medical Center
Study of Wearable Devices and Educational Tools to Manage Long COVID, MECFS, and POTS Symptoms in Adults
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Risk and protective factors related to children's symptoms of emotional difficulties and hyperactivity/inattention during the COVID-19-related lockdown in France: results from a community sample.
Flore Moulin, Tarik El-Aarbaoui, Joel José Herranz Bustamante...
COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement.